Cosmetics and other non-drug lotions aren’t high on the FDA’s list of CBD concerns, but the agency acknowledges in the report that the ingredient’s use in those products likely will grow. That because using CBD in the products isn’t prohibited unless it renders a product adulterated or misbranded.

If CBD or hemp-derived ingredient used in a cosmetic is found to be harmful, as a “poisonous or deleterious substance that may render it injurious when used” as indicated, the product is adulterated. Lotions and other non-drug topicals containing CBD are misbranded, as well as adulterated, when its labeled use is to affect the structure or function of the body or it’s intended for therapeutic or other drug use, according to the report.

The agency says “clinical evidence of safety with respect to the dermal penetration and sensitization of topically applied CBD products is lacking,” and its use in cosmetics “is an area where FDA is working to help address data gaps.”

Confidentiality For Proprietary Information Drives FDA Plan To Generate More CBD Safety Data

More from Regulation

More from Policy & Regulation